NANOSTRING

Serial Number 87977815
Registration 5537412
702

Registration Progress

Application Filed
Mar 28, 2017
Under Examination
Oct 17, 2017
Approved for Publication
Aug 22, 2017
Published for Opposition
Aug 22, 2017
Registered
Aug 7, 2018

Trademark Image

NANOSTRING

Basic Information

Serial Number
87977815
Registration Number
5537412
Filing Date
March 28, 2017
Registration Date
August 7, 2018
Published for Opposition
August 22, 2017
Drawing Code
3

Status Summary

Current Status
Active
Status Code
702
Status Date
Nov 16, 2024
Registration
Registered
Classes
001 005 042

Rights Holder

BRUKER SPATIAL BIOLOGY, INC.

03
Address
40 MANNING ROAD
BILLERICA, MA 01821

Ownership History

NanoString Technologies, Inc.

Original Applicant
03
Seattle, WA

NanoString Technologies, Inc.

Owner at Publication
03
Seattle, WA

NanoString Technologies, Inc.

Original Registrant
03
Seattle, WA

BRUKER SPATIAL BIOLOGY, INC.

New Owner After Registration #1
03
BILLERICA, MA

Legal Representation

Attorney
Alyssa Worsham

USPTO Deadlines

Next Deadline
934 days remaining
Section 8 & 9 Renewal Due (Principal Register) (Based on registration date 20180807)
Due Date
August 07, 2028
Grace Period Ends
February 07, 2029

Application History

35 events
Date Code Type Description Documents
Nov 16, 2024 NA85 E NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED Loading...
Nov 16, 2024 C15A O REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. Loading...
Nov 16, 2024 APRE A CASE ASSIGNED TO POST REGISTRATION PARALEGAL Loading...
Jul 4, 2024 ASGN I AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP Loading...
Jun 3, 2024 E815 I TEAS SECTION 8 & 15 RECEIVED Loading...
Aug 7, 2023 REM1 E COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED Loading...
Mar 18, 2020 ASCK I ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY Loading...
Aug 7, 2018 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Jun 30, 2018 SUNA E NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED Loading...
Jun 29, 2018 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Loading...
Jun 9, 2018 MDSC E NOTICE OF DESIGN SEARCH CODE E-MAILED Loading...
Jun 8, 2018 SUPC I STATEMENT OF USE PROCESSING COMPLETE Loading...
Jun 4, 2018 IUAF S USE AMENDMENT FILED Loading...
Jun 8, 2018 DPCC D DIVISIONAL PROCESSING COMPLETE Loading...
Jun 4, 2018 DRRR I DIVISIONAL REQUEST RECEIVED Loading...
Jun 8, 2018 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Jun 4, 2018 ERTD I TEAS REQUEST TO DIVIDE RECEIVED Loading...
Jun 4, 2018 EISU I TEAS STATEMENT OF USE RECEIVED Loading...
Apr 3, 2018 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Mar 30, 2018 EX1G S SOU EXTENSION 1 GRANTED Loading...
Mar 30, 2018 EXT1 S SOU EXTENSION 1 FILED Loading...
Mar 30, 2018 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Oct 17, 2017 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Aug 22, 2017 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Aug 22, 2017 PUBO A PUBLISHED FOR OPPOSITION Loading...
Aug 2, 2017 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Jun 23, 2017 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jun 22, 2017 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Jun 22, 2017 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Jun 22, 2017 GNEA F EXAMINERS AMENDMENT E-MAILED Loading...
Jun 22, 2017 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Jun 20, 2017 DOCK D ASSIGNED TO EXAMINER Loading...
Apr 4, 2017 MDSC E NOTICE OF DESIGN SEARCH CODE E-MAILED Loading...
Apr 1, 2017 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Mar 31, 2017 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 001
Diagnostic reagents for scientific or research use in the field of cancer; diagnostic reagents for scientific research relating to molecular identification and digital quantification; diagnostic reagent kits comprising primarily diagnostic reagents for scientific or research use in the field of cancer; diagnostic test kits for scientific use comprising reagents, slides, solid matrix materials, microfluidic devices and support documentation, namely, instructional manuals, therefor; diagnostic test kits comprising reagents for scientific research relating to molecular identification and digital quantification; diagnostic reagents for in vitro use in biochemistry, clinical chemistry and microbiology; diagnostic reagents for clinical or medical laboratory use, namely, reagents for proteomics, RNA transcription and microRNA expression profiling, small- molecule analysis, single nucleotide polymorphisms analysis, DNA sequencing, detection of polymorphisms in human fluids, detection of copy number variations, and clinical, oncology, and hematology diagnostics; multiparameter quantitative detection and analysis products and technology for research and diagnostics for a variety of uses in the health care and other life science sectors, namely, reagents for scientific or medical research use, diagnostic preparations and reagents for scientific or research uses, namely, RNA transcription profiling, proteomics, clinical diagnostics, environmental monitoring, biosurveillance, agricultural inspection, forensic testing of samples containing microorganisms or human fluids, small-molecule analysis, single nucleotide polymorphisms analysis, and DNA sequencing; test kits, consisting of chemical preparations for scientific purposes, in particular for the detection, diagnosis, progress monitoring and progress prediction of diseases, including inflammations, infections, disorders of the central nervous systems, cardiovascular, neurological, endocrine, autoimmune and genetic disorders and cancers; assays, reagents, enzymes, polymerases, buffers and nucleotides, and kits comprised thereof, all for scientific or research use; multiparameter quantitative detection and analysis products and technology for research and diagnostics for a variety of uses in life science sectors namely, diagnostic reagents for scientific in vitro use in biochemistry, clinical chemistry and microbiology, RNA and microRNA expression transcription profiling, proteomics, clinical diagnostics, environmental monitoring, agricultural inspection, small- molecule analysis, single nucleotide polymorphisms analysis, and DNA sequencing
First Use Anywhere: Aug 30, 2017
First Use in Commerce: Aug 30, 2017
Class 005
Diagnostic reagents for medical use in the field of cancer; diagnostic reagent kits comprising primarily of diagnostic reagents for medical use in the field of cancer; chemical reagents for medical use; diagnostic test kits for medical use comprising primarily reagents, slides, solid matrix materials, microfluidic devices sold as a unit with instructional manuals therefor; medical diagnostic test kits for detecting pathogens, comprising primarily reagents, slides, solid matrix materials, microfluidic devices sold as a unit and instructional manuals therefor; medical diagnostic kits comprising medical diagnostic reagents for use in detecting the presence of analytes in samples and identifying sample type, and equipment, namely, medical diagnostic immuno-assays for screening samples detecting the presence of analytes in samples and identifying sample type, sold as a unit with instructional manuals; replacement parts for medical diagnostic kits for use in detecting the presence of analytes in samples and identifying sample type in the nature of equipment, namely, medical diagnostic immune-assays for screening samples detecting the presence of analytes in samples and identifying sample type; medical diagnostic reagents for RNA transcription and microRNA expression profiling, proteomics, small molecule analysis, single nucleotide polymorphisms analysis, DNA sequencing, detection of polymorphisms in human fluids, detection of copy number variations, and clinical, oncology, and hematology diagnostics; multiparameter quantitative detection and analysis products and technology for diagnostics for a variety of uses in health care namely, medical diagnostic reagents for RNA and microRNA expression transcription profiling, proteomics, clinical diagnostics, environmental monitoring, agricultural inspection, small-molecule analysis, single nucleotide polymorphisms analysis, and DNA sequencing; tests designed to isolate and extract cells for genetic analysis, namely, reagents for medical diagnostic use; medical diagnostic reagents and assays for testing of body fluids; kits consisting primarily of medical diagnostic reagents and assays for testing of body fluids; reagents in the form of cell markers and molecule markers for medical purposes
First Use Anywhere: Jan 30, 2018
First Use in Commerce: Jan 30, 2018
Class 042
Research and product development services for others in the field of biotechnology; medical and scientific research in the field of cancer treatment and diagnosis; providing laboratory research services in the field of gene expression; genetic data mining; providing molecule identification methods for acquiring, analyzing and managing biological and genetic information, in the fields of genetics and environment; research and development services for others in the field of diagnostic compounds for use in medicine, measuring apparatus for use in product research and development, separation and purification processes, environmental and testing processes, and industrial quality control processes; developing systems for acquiring, analyzing, and managing biological and genetic information in the fields of diagnostic reagents, forensics, medicine, genetics, and environment; research, design, and development services for others in the fields of diagnostic reagents, compounds and devices, measuring apparatus for use in product research and development, separation and purification processes, environmental and testing processes and industrial quality control processes; chemical screening analysis for others
First Use Anywhere: May 5, 2017
First Use in Commerce: May 5, 2017

Additional Information

Design Mark
The mark consists of the word "nanoString" with a line below the word containing circles.
Color Claim
Color is not claimed as a feature of the mark.

Classification

International Classes
001 005 042